Tanya Lewis - 01 Mar 2023 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
3
Filing time
06 Mar 2023, 16:06:10 UTC
Previous filing
18 May 2022
Next filing
04 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 0 01 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.